# Moderna, Inc. (MRNA) FY2024 Annual P&L / Income Statement

- Company: Moderna, Inc. (MRNA)
- Period: 2024-01-01 to 2024-12-31
- Filing: FY2024 10-K, filed 2025-02-21, accession number 0001682852-25-000022
- Page: https://plicit.ai/financials/mrna/fy2024-annual-income-statement
- Chart image: https://plicit.ai/charts/mrna-fy2024-annual-income-statement-sankey.png

## Chart details: Revenue by Product and Service by Geography

Income statement for 2024-01-01 through 2024-12-31. View: Product and Service by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 3,236,000,000 US dollars
- **Cost of sales**: 1,464,000,000 US dollars
- **Gross profit (calculated)**: 1,772,000,000 US dollars
- **Operating expenses (calculated)**: 5,717,000,000 US dollars
- **(Loss) income from operations**: negative 3,945,000,000 US dollars
- **Other income (expense), net (calculated)**: 338,000,000 US dollars
- **(Loss) income before income taxes**: negative 3,607,000,000 US dollars
- **(Benefit from) provision for income taxes**: negative 46,000,000 US dollars
- **Net (loss) income**: negative 3,561,000,000 US dollars
- **Licensing and royalty revenue**: 42,000,000 US dollars
- **Grant revenue**: 37,000,000 US dollars
- **Collaboration revenue (Note 5)**: 48,000,000 US dollars
- **Net product sales - UNITED STATES**: 1,726,000,000 US dollars
- **Net product sales - Rest of world**: 810,000,000 US dollars
- **Net product sales - Europe**: 573,000,000 US dollars
- **Research and development**: 4,543,000,000 US dollars
- **Selling, general and administrative**: 1,174,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service (4)

- Page: https://plicit.ai/financials/mrna/fy2024-annual-income-statement/revenue-by-product-and-service-4
- Chart image: https://plicit.ai/charts/mrna-fy2024-annual-revenue-by-product-and-service-4-sankey.png

Income statement for 2024-01-01 through 2024-12-31. View: Product and service (Narrative) (2). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 3,236,000,000 US dollars
- **Cost of sales**: 1,464,000,000 US dollars
- **Gross profit (calculated)**: 1,772,000,000 US dollars
- **Operating expenses (calculated)**: 5,717,000,000 US dollars
- **(Loss) income from operations**: negative 3,945,000,000 US dollars
- **Other income (expense), net (calculated)**: 338,000,000 US dollars
- **(Loss) income before income taxes**: negative 3,607,000,000 US dollars
- **(Benefit from) provision for income taxes**: negative 46,000,000 US dollars
- **Net (loss) income**: negative 3,561,000,000 US dollars
- **Licensing and royalty revenue**: 42,000,000 US dollars
- **Other revenue**: 127,000,000 US dollars
- **Undisclosed (calculated)**: 3,067,000,000 US dollars
- **Research and development**: 4,543,000,000 US dollars
- **Selling, general and administrative**: 1,174,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/mrna/fy2024-annual-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/mrna-fy2024-annual-revenue-by-geography-sankey.png

Income statement for 2024-01-01 through 2024-12-31. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 3,236,000,000 US dollars
- **Cost of sales**: 1,464,000,000 US dollars
- **Gross profit (calculated)**: 1,772,000,000 US dollars
- **Operating expenses (calculated)**: 5,717,000,000 US dollars
- **(Loss) income from operations**: negative 3,945,000,000 US dollars
- **Other income (expense), net (calculated)**: 338,000,000 US dollars
- **(Loss) income before income taxes**: negative 3,607,000,000 US dollars
- **(Benefit from) provision for income taxes**: negative 46,000,000 US dollars
- **Net (loss) income**: negative 3,561,000,000 US dollars
- **UNITED STATES**: 1,785,000,000 US dollars
- **Europe**: 598,000,000 US dollars
- **Rest of world**: 853,000,000 US dollars
- **Research and development**: 4,543,000,000 US dollars
- **Selling, general and administrative**: 1,174,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Counterparty Name

- Page: https://plicit.ai/financials/mrna/fy2024-annual-income-statement/revenue-by-counterparty-name
- Chart image: https://plicit.ai/charts/mrna-fy2024-annual-revenue-by-counterparty-name-sankey.png

Income statement for 2024-01-01 through 2024-12-31. View: Counterparty Name. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 3,236,000,000 US dollars
- **Cost of sales**: 1,464,000,000 US dollars
- **Gross profit (calculated)**: 1,772,000,000 US dollars
- **Operating expenses (calculated)**: 5,717,000,000 US dollars
- **(Loss) income from operations**: negative 3,945,000,000 US dollars
- **Other income (expense), net (calculated)**: 338,000,000 US dollars
- **(Loss) income before income taxes**: negative 3,607,000,000 US dollars
- **(Benefit from) provision for income taxes**: negative 46,000,000 US dollars
- **Net (loss) income**: negative 3,561,000,000 US dollars
- **AstraZeneca**: 0 US dollars
- **Merck**: 0 US dollars
- **Other**: 25,000,000 US dollars
- **Vertex**: 23,000,000 US dollars
- **Undisclosed (calculated)**: 3,188,000,000 US dollars
- **Research and development**: 4,543,000,000 US dollars
- **Selling, general and administrative**: 1,174,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service

- Page: https://plicit.ai/financials/mrna/fy2024-annual-income-statement/revenue-by-product-and-service
- Chart image: https://plicit.ai/charts/mrna-fy2024-annual-revenue-by-product-and-service-sankey.png

Income statement for 2024-01-01 through 2024-12-31. View: Product and service (Schedule of Disaggregation of Revenue). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 3,236,000,000 US dollars
- **Cost of sales**: 1,464,000,000 US dollars
- **Gross profit (calculated)**: 1,772,000,000 US dollars
- **Operating expenses (calculated)**: 5,717,000,000 US dollars
- **(Loss) income from operations**: negative 3,945,000,000 US dollars
- **Other income (expense), net (calculated)**: 338,000,000 US dollars
- **(Loss) income before income taxes**: negative 3,607,000,000 US dollars
- **(Benefit from) provision for income taxes**: negative 46,000,000 US dollars
- **Net (loss) income**: negative 3,561,000,000 US dollars
- **Grant revenue**: 37,000,000 US dollars
- **Collaboration revenue (Note 5)**: 48,000,000 US dollars
- **Licensing and royalty revenue**: 42,000,000 US dollars
- **Total other revenue**: 127,000,000 US dollars
- **Undisclosed (calculated)**: 2,982,000,000 US dollars
- **Research and development**: 4,543,000,000 US dollars
- **Selling, general and administrative**: 1,174,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service (5)

- Page: https://plicit.ai/financials/mrna/fy2024-annual-income-statement/revenue-by-product-and-service-5
- Chart image: https://plicit.ai/charts/mrna-fy2024-annual-revenue-by-product-and-service-5-sankey.png

Income statement for 2024-01-01 through 2024-12-31. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 3,236,000,000 US dollars
- **Cost of sales**: 1,464,000,000 US dollars
- **Gross profit (calculated)**: 1,772,000,000 US dollars
- **Operating expenses (calculated)**: 5,717,000,000 US dollars
- **(Loss) income from operations**: negative 3,945,000,000 US dollars
- **Other income (expense), net (calculated)**: 338,000,000 US dollars
- **(Loss) income before income taxes**: negative 3,607,000,000 US dollars
- **(Benefit from) provision for income taxes**: negative 46,000,000 US dollars
- **Net (loss) income**: negative 3,561,000,000 US dollars
- **Net product sales**: 3,109,000,000 US dollars
- **Other revenue**: 127,000,000 US dollars
- **Research and development**: 4,543,000,000 US dollars
- **Selling, general and administrative**: 1,174,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service (2)

- Page: https://plicit.ai/financials/mrna/fy2024-annual-income-statement/revenue-by-product-and-service-2
- Chart image: https://plicit.ai/charts/mrna-fy2024-annual-revenue-by-product-and-service-2-sankey.png

Income statement for 2024-01-01 through 2024-12-31. View: Product and service (Net Product Sales by Customer Geographic Areas). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 3,236,000,000 US dollars
- **Cost of sales**: 1,464,000,000 US dollars
- **Gross profit (calculated)**: 1,772,000,000 US dollars
- **Operating expenses (calculated)**: 5,717,000,000 US dollars
- **(Loss) income from operations**: negative 3,945,000,000 US dollars
- **Other income (expense), net (calculated)**: 338,000,000 US dollars
- **(Loss) income before income taxes**: negative 3,607,000,000 US dollars
- **(Benefit from) provision for income taxes**: negative 46,000,000 US dollars
- **Net (loss) income**: negative 3,561,000,000 US dollars
- **COVID-19**: 3,084,000,000 US dollars
- **RSV**: 25,000,000 US dollars
- **Other revenue**: 127,000,000 US dollars
- **Research and development**: 4,543,000,000 US dollars
- **Selling, general and administrative**: 1,174,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Product and Service (3)

- Page: https://plicit.ai/financials/mrna/fy2024-annual-income-statement/revenue-by-product-and-service-3
- Chart image: https://plicit.ai/charts/mrna-fy2024-annual-revenue-by-product-and-service-3-sankey.png

Income statement for 2024-01-01 through 2024-12-31. View: Product and service (Narrative). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenue**: 3,236,000,000 US dollars
- **Cost of sales**: 1,464,000,000 US dollars
- **Gross profit (calculated)**: 1,772,000,000 US dollars
- **Operating expenses (calculated)**: 5,717,000,000 US dollars
- **(Loss) income from operations**: negative 3,945,000,000 US dollars
- **Other income (expense), net (calculated)**: 338,000,000 US dollars
- **(Loss) income before income taxes**: negative 3,607,000,000 US dollars
- **(Benefit from) provision for income taxes**: negative 46,000,000 US dollars
- **Net (loss) income**: negative 3,561,000,000 US dollars
- **Licensing and royalty revenue**: 42,000,000 US dollars
- **Other revenue**: 127,000,000 US dollars
- **Grant revenue**: 37,000,000 US dollars
- **Undisclosed (calculated)**: 3,030,000,000 US dollars
- **Research and development**: 4,543,000,000 US dollars
- **Selling, general and administrative**: 1,174,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.